PharmiWeb.com - Global Pharma News & Resources
10-Jul-2019

VALIRX PLC MARKETING AND COMMUNICATIONS UPDATE

London, UK., 10 July 2019: ValiRx Plc (AIM: VAL), the AIM-quoted clinical stage biotechnology company is pleased to announce a marketing and communications update for shareholders.

 

Dr Satu Vainikka, Chief Executive, will be delivering a presentation to investors at the SVS Securities and UK Investor Magazine investor evening on Thursday 18 July 2019 at the Skinners Hall, 8½ Dowgate Hill, London EC4R 2SP, which commences at 6:00pm (for registration) until 11:00pm.

 

Those wishing to register for this complimentary event may do so through the following link:

 

https://www.eventbrite.co.uk/e/uk-investor-magazine-svs-securities-summer-investor-evening-tickets-62427386995

 

A copy of the presentation will be available to investors on the evening and will be available to view on the Company’s website shortly after the event.

Editor Details

  • Name:
    • Tarquin Edwards
  • Telephone:
    • +442030084416
Last Updated: 10-Jul-2019